BORRONI, Riccardo G. et al. Real-life Effectiveness and Safety of Risankizumab in Moderate-to-severe Plaque Psoriasis: A 40-week Multicentric Retrospective Study. Acta Dermato-Venereologica, [S. l.], v. 101, n. 11, p. adv00605, 2021. DOI: 10.2340/actadv.v101.283. Disponível em: https://medicaljournalssweden.se/actadv/article/view/283. Acesso em: 22 nov. 2024.